跳至主要内容
临床试验/NCT01477320
NCT01477320已完成不适用

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.

Mohamed Saad1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
124
试验地点
1
主要终点
Number of Subjects With GI Bleeding

研究概览

简要总结

study is to determine if proton pump inhibitors plus enteral nutrition is superior to enteral nutrition alone as a stress ulcer prophylaxis strategy in critically ill patients in terms of incidence of overt and significant GI bleeding related to stress gastropathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Admission to the medical ICU at University of Louisville Hospital or Jewish Hospital
  • Expected need for mechanical ventilation > 48 hours
  • No contraindication to EN within the first 24 hours after admission to the ICU

排除标准

  • Evidence of active GI bleeding during current hospitalization prior to study entry
  • Admission to ICU with primary diagnosis of burn injury
  • Closed head injury or increased intracranial pressure
  • Partial or complete gastrectomy
  • Pregnancy or lactation

研究组 & 干预措施

Pantoprazole 40mg IV daily and tube feed

Active Comparator

干预措施: Pantoprazole 40 mg IV daily and tube feed. (Drug)

Placebo and tube feed.

Placebo Comparator

干预措施: Placebo and tube feed (Other)

结局指标

主要结局

Number of Subjects With GI Bleeding

时间窗: Subjects will be followed from date of randomization until discharge from the ICU or cessation of Enteral Nutrition (EN) and successful initiation of oral feeds up to 100 weeks.

1. Incidence of overt GI bleeding (as defined by the presence of coffee ground emesis, hematemesis of bright red blood, melena, or hematochezia) seen with Proton Pump Inhibitor (PPI) and EN versus EN alone in critically ill patients. 2. Incidence of significant GI bleeding, defined by a 3-point decrease in hematocrit within 24 hours accompanied by signs of overt GI bleeding, or by an unexplained 6-point decrease in hematocrit during any 48 hour period.

次要结局

  • Number of Subjects With ICU-acquired C. Difficile Pseudomembranous Colitis.(Subjects will be followed until discharge from the ICU or cessation of EN and successful initiation of oral feeds up to 100 weeks.)

研究者

发起方
Mohamed Saad
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mohamed Saad

Primary Investigator

University of Louisville

研究点 (1)

Loading locations...

相似试验